- Home
- / Quest PharmaTech
Quest PharmaTech
Stock Price
$0
2024-10-29
Market Capitalization
$4.2 M
2024-10-29
Quest PharmaTech Summary
Company Summary
- Overview
- Quest PharmaTech is a pharmaceutical company that develops drugs with a focus on the treatment of cancer. It is engaed in the production of antibody based immunotherapeutic products and owns the photodynamic therapy technology for oncology and dermatology applications.
- Type
- Public
- Status
- Active
- HQ
- Edmonton, CA | view all locations
- Cybersecurity rating
Table of Contents
Key People
Lorne Meikle, Chairman, Director
W. John Meekison, Director
J. Mark Lievonen, Director
LocationsView all
1 location detected
Edmonton, AB HQ
Canada
8123 Roper Rd NW
Quest PharmaTech Financials
Summary Financials
- Net income (Q2, 2026)
- ($C176.0K)
- Cash (Q2, 2026)
- $C93.0K
- EBIT (Q2, 2026)
- ($C168.0K)
- Enterprise value
- $5.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026